You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

54 Results
Drug
Other Name(s): Zometa®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Feb 2024
Cancer facts
May 2015
Cancer facts
Feb 2018
Cancer facts
Sep 2015
Guidelines and Advice
Status: Current
ID: GL 2-21
Version: 2
Mar 2024
Guidelines and Advice
Status: In-Review
ID: 19-6
Apr 2016
Guidelines and Advice
Status: Archived
ID: CED 5
May 2007
Guidelines and Advice
Status: Archived
ID: 14-3
Jul 2005
Guidelines and Advice
Status: Current
ID: GL-C50-01
Jan 2011
Cancer facts
Jul 2018
Cancer facts
Mar 2023
Regimen
Cancer Type:
Endocrine, 
Thyroid
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    cabozantinib - For the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma that has progressed following prior VEGFR-targeted therapy and who are radioactive iodine-refractory or ineligible
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cabozantinib (tablet)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2024

Pages